| Drug Name |
Testosterone undecanoate |
| Drug ID |
BADD_D02174 |
| Description |
Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position. [A176753] It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency. [F4247][FDA Label] It should be noted that testosterone undecanoate is only indicated for treatment of hypogonadal conditions with structural or genetic etiologies and should not be used to manage "age-related hypogonadism". [FDA Label] |
| Indications and Usage |
Testosterone undecanoate is indicated as a testosterone replacement therapy in adult males that present conditions of deficiency or absence of endogenous testosterone. The approved conditions for the use of testosterone undecanoate are 1) primary hypogonadism, defined as a testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy or toxic damage from alcohol or heavy metals: or 2) hypogonadotropic hypogonadism caused by idiopathic gonadotropin or luteinizing hormone-releasing hormone deficiency or pituitary-hypothalamic injuries from tumors, trauma or radiation.[FDA label] |
| Marketing Status |
Prescription |
| ATC Code |
G03BA03 |
| DrugBank ID |
DB13946
|
| KEGG ID |
D06087
|
| MeSH ID |
C010792
|
| PubChem ID |
65157
|
| TTD Drug ID |
D02AXG
|
| NDC Product Code |
11014-0385; 69087-237; 60722-0009; 60870-0465; 11014-0386; 51552-1598; 49803-003; 48087-0135; 54436-112; 22552-0013; 11014-0387; 60722-3007; 69087-158; 0009-5036; 69087-198; 67979-511 |
| Synonyms |
testosterone undecanoate | testosterone undecylate | Andriol | Restandol | Pantestone | Nebido | Undestor |
